
Objective(s): Sunitinib resistance remains a major obstacle in the treatment of renal cell carcinoma (RCC). This study sought to construct a targeted nanoparticle-based delivery system for silencing methyltransferaselike 14 (METTL14), with the aim of restoring drug responsiveness in resistant RCC. Methods: Hyaluronic acid-functionalized poly (lactic-co-glycolic acid) nanoparticles (HA-PLGA-NPs) were engineered to encapsulate METTL14 siRNA. Their physicochemical characteristics, targeting capability toward CD44-positive sunitinib-resistant RCC cells (786-O-SUR and ACHN-SUR), and therapeutic performance were systematically evaluated in vitro. Transcriptomic analysis was conducted to investigate underlying mechanisms. Antitumor efficacy and biosafety were further examined in a xenograft mouse model. Results: The fabricated nanoparticles displayed uniform morphology, appropriate particle size, and high siRNA encapsulation efficiency (>88%), along with favorable stability. HA modification significantly improved cellular uptake in CD44-positive resistant cells compared with non-targeted nanoparticles. Delivery of METTL14 siRNA via HA-PLGA-NPs markedly reduced the IC50 of sunitinib, increased apoptotic cell death, and effectively reversed drug resistance. In vivo, treatment with HA-PLGA (METTL14 siRNA)-NPs led to substantial tumor growth inhibition. RNA sequencing indicated that METTL14 silencing was associated with pathways involved in apoptosis, cell cycle regulation, and immune-related processes. No obvious systemic toxicity was observed. Conclusion: HA-PLGA nanoparticles provide an effective and selective platform for METTL14 siRNA delivery, enabling reversal of sunitinib resistance in RCC models. This approach offers a potential therapeutic strategy for overcoming drug resistance in renal cell carcinoma.
Objective(s): This study aimed to improve the oral bioavailability of Rilpivirine by creating and testing Rilpivirine solid lipid nanoparticles (SLNs) to determine the impact of drug delivery on pharmacokinetics following oral treatment in Wistar rats. Materials and Methods: Solid lipid nanoparticles (SLNs) were fabricated using a high-pressure homogenization technique, after which they were evaluated for their physicochemical properties including particle size, morphology, zeta potential, encapsulation efficiency as well as their in vitro release behaviour, ex vivo permeability, and in vivo pharmacokinetics in Wistar rats. To further understand how SLNs are taken up through the lymphatic system, an ex vivo study was carried out using an everted rat intestinal sac model. Results: The resulting SLNs were spherical, showing an average particle size of 74.45 +/- 0.84 nm with a PDI of 0.27, zeta potential -17.49 +/- 0.82 mV, and an entrapment efficiency of 62.9 +/- 1.2%. The SLN formulation demonstrated 84% drug release over a 24-hour period. In an ex vivo study using everted rat intestine, the SLN's apparent permeability was 34.2 & times; 10(-6) at 37 +/- 0.5 degrees C without chlorpromazine. This value decreased to 14.6 & times; 10(-6 )when chlorpromazine was present. Pharmacokinetic studies in rats showed the SLN formulation's AUC was 1.04 times higher than that of the pure drug suspension. Conversely, adding the lymphatic uptake inhibitor chlorpromazine reduced the SLN's AUC by 0.52-fold. The in vivo pharmacokinetic data was assessed by Dunnett's test, which indicated a significant difference (p < 0.05) between the RLV SLNs and the plain RLV drug. Conclusion: Employing SLNs as a delivery vehicle appears to be a viable method for boosting the therapeutic efficacy of rilpivirine. A key reason is that SLN lymphatic uptake is important for avoiding hepatic first-pass metabolism.
Objective(s): A significant problem in osteosarcoma treatment and bone regeneration is the creation of biomaterials that efficiently target cancer cells while concurrently facilitating bone tissue regeneration. We introduce an innovative dual-action nanomedicine, catechin-functionalized nano cerium-hydroxyapatite (CH@Ce-HA), aimed at addressing these constraints by integrating cytotoxic and regenerative capacity. Materials and Methods: The CH@Ce-HA composite was created by integrating the natural anticancer and antioxidant compound, catechin, onto a nanoscale cerium-doped hydroxyapatite matrix. The physicochemical analysis via FT-IR revealed the incorporation of catechin, while XRD validated the retention of the HA crystalline structure. TEM examination demonstrated a homogeneous distribution of nanoparticles ranging from 20 to 50 nm in size. The combined therapeutic efficacy was further examined in vitro utilizing osteosarcoma and osteoblast cell lines, evaluating cell proliferation, oxidative stress reduction, apoptosis induction, and osteogenic differentiation. Results: In vitro investigations utilizing osteosarcoma and osteoblast cell lines demonstrated the nanocomposite's exceptional therapeutic flexibility. The CH@Ce-HA demonstrated improved antioxidant activity and a strong nanomedicine effect against MG63 osteosarcoma cells, markedly suppressing proliferation, diminishing harmful oxidative stress, and effectively inducing apoptosis. The nanocomposite significantly improved osteoblast proliferation, differentiation, and mineralization. Conclusion: This study presents a potential, multifunctional ceramic based therapeutic agent that functions at the nanoscale to offer a comprehensive treatment for bone oncology. The CH@Ce-HA nanocomposite integrates targeted cytotoxic effects with robust osteogenic and antioxidant properties, marking a notable progress in translational nanomedicine treating challenging bone abnormalities and cancers.
Objectives: L-ascorbic acid (AA, vitamin C), has important bodily functions, including immune defense, collagen formation, and metabolism. Symptoms of many diseases like cancer or cardiovascular disorders can be observed owing to maladjustment or deficiency. Hence, developing sensitive and rapid methods to determine AA in biological samples is essential. In this study, a novel electrochemical sensing assay based on Zn metal-organic framework embedded in multi-walled carbon nanotubes (Zn-MOF/MWCNTs) has been effectively developed to modify glassy carbon electrode (GCE). Materials and Methods: Zn-MOF was synthesized using the solvothermal technique and mixed with multi-walled carbon nanotubes to obtain a modifier suspension. Various characterization methods including XRD (X-ray Diffraction), EDX (Energy-dispersive X-ray spectroscopy), HR-TEM (High-resolution transmission electron microscopy), FT-IR (Fourier-transform infrared spectroscopy), and FESEM (Field emission scanning electron microscopy) were applied to confirm the proper synthesis of Zn-MOF. Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) approaches were employed to study the electrochemical behavior of the modified GCE and electrochemical determination of AA with high sensitivity. Results: Under the optimized conditions including the drop volume, supporting electrolyte type and concentration, buffer type and concentration, and pH, the linear range and LOD (detection limit) were acquired 2-22 mu M equal to 1.211 mu M respectively. Moreover, other prominent analytical features including repeatability, stability, and high reproducibility were investigated for the proposed sensing platform. Additionally, the prepared sensor was effectively utilized for determination of AA in human plasma samples, attaining a recovery of 93.1%. Conclusion: These findings clearly confirm that the developed Zn-based MOF/MWCNT sensing assay is a promising platform for accurate and effective AA determination in real biological samples, and confirms its potential for feasible biomedical applications.
Cell-penetrating peptides (CPPs) are a group of short peptides that easily pass through the cell membrane and are able to carry various types of cargoes, such as drugs, nucleic acids, and proteins, into cells. Therefore, CPPs are investigated with the aim of effective drug delivery to treat diseases such as cancer, diabetes and genetic disorders. CPPs have different applications in different fields.CPPs have common functions and some structural features, such as a high content of positively charged amino acids, but their structural differences are in the high variety of elements in them. In this paper, the effect of cell penetrating peptides on the efficiency of lipid nanoparticles containing chemotherapeutics is reviewed. Various drug delivery systems such as liposomes, solid lipid nanoparticles and exosomes were considered. Both in-vitro and in-vivo delivery routes were discussed.